Two years ago, I made a decision that most of my colleagues would question and none of my patients would hear me endorse: I started injecting low-dose tirzepatide — not for weight loss, not for diabetes, but for something far less conventional. I did it because the evidence, while incomplete, pointed toward a drug whose benefits might extend well beyond the indications printed on the label. And I did it because I'm the kind of physician who believes that if you're going to speak with conviction about a medication, you should understand what it actually feels like to take it.
What started as an exercise in empathy — a doctor trying to develop a shared vocabulary with his patients — became something I didn't expect. It became personal.
A Necessary Disclaimer
I do not endorse using tirzepatide or any GLP-1 receptor agonist in the way I describe in this article. My decision was informed by years of clinical training, a deep understanding of the pharmacology involved, and a personal risk tolerance that may differ significantly from yours. I cannot in good conscience recommend an approach where others are not afforded the same level of informed consent that my background provides. What follows is my experience — not a prescription.